Outcome of Board Meeting inter-alia to consider and approve un-audited Standalone and Consolidated financial results for third quarter and nine months ended December 31, 2025.
BNAGROCHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
BN Agrochem Ltd's Board approved un-audited financial results for Q3 and 9M ended December 31, 2025 on February 13, 2026. The auditor JSMG & Associates issued a limited review report with an un-modified (clean) opinion on both results. On a consolidated basis, revenue from operations surged to Rs. 79,271.60 lacs in Q3 FY26 (vs Rs. 8,520.77 lacs in Q3 FY25), while 9M FY26 revenue jumped to Rs. 61,102.20 lacs from Rs. 8,537.56 lacs in 9M FY25. Consolidated PAT for 9M FY26 turned positive at Rs. 3,122.20 lacs compared to a loss of Rs. 248.85 lacs in the prior year period. Standalone Q3 PAT was Rs. 74.76 lacs vs a loss of Rs. 501.73 lacs in Q3 FY25. Diluted EPS for 9M FY26 stood at Rs. 3.19 (consolidated).
The results show a dramatic turnaround driven by very strong revenue growth (likely reflecting the business shift from BN Holdings to BN Agrochem and entry into agrochem operations) and a swing to profitability at both standalone and consolidated levels. A clean (un-modified) auditor opinion removes one layer of risk; shareholders should note the high dependence on subsidiaries (one foreign subsidiary and two step-down subsidiaries contribute significantly to consolidated numbers) and the sharp dip in Q3 standalone PAT compared to Q2, partly because Q2 had a one-time deferred tax credit of Rs. 1,781.26 lacs.